EUMETSAT Moodle
CMSAF
CD BioSciences, an aging research service provider that specializes in anti-aging and aging-related diseases, is delighted to introduce its comprehensive preclinical development services aimed at speeding the research pipeline in the rapidly growing area of anti-aging therapeutics.
According to Statista, the worldwide anti-aging product market size was about
47 billion US dollars in 2023, and it is projected to reach nearly 80 billion by the
start of the next decade. All of this means that the demand for effective
therapies and scientific breakthroughs in this domain has never been greater. CD BioSciences
recognizes the urgent need for robust preclinical strategies to successfully
navigate the complexities of drug development in this rapidly evolving field.
From biomarker discovery to safety pharmacology, CD BioSciences preclinical
development services for anti-aging
drug research span the full range. These services,
by combining advanced technology and scientific know-how, will help
pharmaceutical and biotech companies determine the effectiveness and safety of
drug candidates before they are sent to clinical trials.
“We’re working to provide scientists and biotech companies with the tools and
resources they need to accelerate the research on anti-aging therapies,” said
CD BioSciences’ marketing manager. “By offering full-service preclinical development
support, including aging mechanism analysis, telomere biology study, DNA
methylation research, and multi-omics analysis, we are enabling new research to
be brought to the clinic,” added the manager.
Committed to excellence and innovation, CD BioSciences not only facilitates research
workflow but also gives detailed reports and analyses to clients so that they
can make informed
decisions.As the demand for unique
anti-aging
strategies grows, the role of
robust preclinical services in identifying promising drug candidates has never
been more critical. Through their dedicated efforts, CD BioSciences is poised
to contribute significantly to the advancement of therapies that can improve the
quality of life for the aging population.